Lephart 2020 [B].

Study characteristics
Patient Sampling	See Lephart 2020 [A] for full study details and QUADAS entries
Patient characteristics and setting
Index tests	Test name: [B] Xpert Xpress (second index test [A] ID NOW, extracted as Lephart 2020 [A], also see see Lephart 2020 [A] for full study details and QUADAS entries; two additional RT‐PCR tests evaluated in study but not included in this review). No product codes reported Manufacturer: [B] Cepheid Target gene: Not reported in paper Test method: [B] Automated RT‐PCR Samples used: [B] NP; presume collected by HCP but not reported Transport media: [B] M4‐RT VTM (Thermo Fisher) Sample storage: [B] stored at 4°C and tested within 24h Test operator: Not stated; presume lab staff Definition of test positivity: each assay was performed according to manufacturer’s EUA instructions (presumptive positives not described) Blinding reported: Not stated; unlikely Timing of samples: On presentation; timing pso not reported
Target condition and reference standard(s)	See Lephart 2020 [A] for full study details and QUADAS entries
Flow and timing	See Lephart 2020 [A] for full study details and QUADAS entries
Comparative
Notes